Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer

This publication has 58 references indexed in Scilit:

• Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
  JAMA, 2000
• INHIBITION OF CYCLOOXYGENASE-2 SUPPRESSES ANGIOGENESIS AND THE GROWTH OF PROSTATE CANCER IN VIVO
  Journal of Urology, 2000
• The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
  New England Journal of Medicine, 2000
• Xenobiotic-metabolizing Cytochromes P450 Convert Prostaglandin Endoperoxide to Hydroxyheptadecatrienoic Acid and the Mutagen, Malondialdehyde
  Journal of Biological Chemistry, 2000
• Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin‐1: a potential mechanism for inflammatory angiogenesis
  Published by Wiley ,2000
• A Selective Cyclooxygenase‐2 Inhibitor Suppresses Tumor Growth in Nude Mouse Xenografted with Human Head and Neck Squamous Carcinoma Cells
  Japanese Journal of Cancer Research, 1999
• Effect of α-Difluoromethylornithine on Rectal Mucosal Levels of Polyamines in a Randomized, Double-Blinded Trial for Colon Cancer Prevention
  JNCI Journal of the National Cancer Institute, 1998
• Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocols
  Carcinogenesis: Integrative Cancer Research, 1997
• Prostaglandin synthase 2
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
• Chemoprevention of OH-BBN-induced bladder cancer in mice by piroxicam
  Carcinogenesis: Integrative Cancer Research, 1993